SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-003232
Filing Date
2014-08-06
Accepted
2014-08-06 17:27:26
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptla-10q_20140630.htm 10-Q 1371893
2 EX-10.4 ptla-ex10_20140630640.htm EX-10 113708
3 EX-31.1 ptla-ex31_20140630507.htm EX-31 14805
4 EX-31.2 ptla-ex31_20140630508.htm EX-31 14683
5 EX-32.1 ptla-ex32_20140630509.htm EX-32 7883
6 GRAPHIC g20140806211008108248.jpg GRAPHIC 33352
  Complete submission text file 0001564590-14-003232.txt   6613012

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ptla-20140630.xml EX-101.INS 1067690
8 XBRL TAXONOMY EXTENSION SCHEMA ptla-20140630.xsd EX-101.SCH 35892
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptla-20140630_cal.xml EX-101.CAL 33973
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptla-20140630_def.xml EX-101.DEF 208494
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptla-20140630_lab.xml EX-101.LAB 273628
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptla-20140630_pre.xml EX-101.PRE 244786
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35935 | Film No.: 141021002
SIC: 2834 Pharmaceutical Preparations